Results 151 to 160 of about 21,720 (281)

Woman‐centeredness of family planning care and associated factors in a semi‐urban health district in West Cameroon

International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 763-773, May 2026.
Abstract Objective To measure the woman‐centeredness of family planning (FP) care and determine its correlates in West Cameroon. Methods We conducted a cross‐sectional analytical study from August to November 2024 in the Mifi Health District (MHD). We included women receiving FP care in all the public health facilities. We collected data were using the
Jovanny Tsuala Fouogue, Wiliams Carter Kenne Djuatio, Armand Tiotsia Tsapi, Ymele Florent Fouelifack, Madye Ange Ngo Dingom, Estelle Diane Modjo Kamdem, Jeanne Hortence Fouelifack Fouedjio   +6 more
wiley   +1 more source

A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception. [PDF]

Front Endocrinol (Lausanne)
Gaspard U, Chatel G, Douxfils J, Stanczyk FZ.   +3 more
europepmc   +1 more source

Associations between Nugent‐bacterial vaginosis and preterm birth and other adverse pregnancy outcomes in rural northwestern Bangladesh

International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 1094-1104, May 2026.
Abstract Objective Bacterial vaginosis, defined by Nugent score (Nugent‐BV), has been associated with preterm birth and other adverse pregnancy outcomes. However, few studies have longitudinally described the associations between Nugent‐BV and adverse pregnancy outcomes at varying times in pregnancy.
Daniel J. Erchick, Susan Tuddenham, Lena Kan, Lee S. F. Wu, Alain B. Labrique, Hasmot Ali, Ethan K. Gough, Mahbubur Rashid, Towfida J. Siddiqua, Subhra Chakraborty, Pawel Gajer, Michael France, Jacques Ravel, Golsa M. Yazdy, Keith P. West, Parul Christian   +15 more
wiley   +1 more source

Hormonal contraceptives and the risk of meningioma: A Swedish register-based case-control study. [PDF]

Neuro Oncol
Tettamanti G, Shu X, Mogensen H, Kopp Kallner H, Mathiesen T, Feychting M.   +5 more
europepmc   +1 more source

Assessment of the Drug–Drug Interaction Potential of Lotiglipron (PF‐07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol

The Journal of Clinical Pharmacology, Volume 66, Issue 5, May 2026.
Abstract Two Phase 1 open‐label studies were conducted in otherwise healthy participants, with BMI classified as overweight/obesity, to assess the potential of lotiglipron (a glucagon‐like peptide‐1 receptor agonist) as precipitant for pharmacokinetic (PK) drug–drug interactions (DDIs) when co‐administered with substrates of cytochrome P450 (CYP) 3A ...
Carol Cronenberger, Neeta B. Amin, Vu H. Le, Santos Carvajal‐Gonzalez, Amy L. Ashworth, Ellen C. Yi, Tilman Schuster, Yizhong Zhang, Robert C. Frederich, Gary S. Friedman, Ellen Q. Wang, Nikolaos Tsamandouras   +11 more
wiley   +1 more source

Clinical and endocrine effects of pharmacological therapy in endometriosis: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Sun R, Xu H, Ma R, Xu J, Liu Y, Mao D.
europepmc   +1 more source

Oral Contraceptives: Nature, Use and Physiological Effects [PDF]

, 1966
Maledon, Anne R.
core   +1 more source

Proteomic Analysis of Cervicovaginal Fluid for Diagnostic Endometriosis Biomarker Discovery

PROTEOMICS – Clinical Applications, Volume 20, Issue 3, May 2026.
ABSTRACT Purpose Endometriosis is a prevalent inflammatory condition characterised by the presence of endometrial‐like tissue outside the uterus and is associated with significant challenges, including diagnostic delays and continued reliance on laparoscopy.
Emily S. J. Paterson, Simon Scheck, Torsten Kleffmann, Roopi Gill, Nicholas Bedford, Simon McDowell, Jane E. Girling, Claire E. Henry   +7 more
wiley   +1 more source

Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†. [PDF]

Biol Reprod
Bick AJ, Avenant C, Capitaine CK, van Eck S, Lee MT, Moliki JM, Dlamini S, Erikson DW, Smit J, Beksinska M, Hofmeyr GJ, Africander DJ, Chen PL, Hapgood JP.   +13 more
europepmc   +1 more source

Sexual Function, Activity and Distress 24 Months After Surgical Menopause: What Happens After Menopause (WHAM)—A Prospective Controlled Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 6, Page 1188-1199, May 2026.
ABSTRACT Objective To determine the effect of surgical menopause (risk‐reducing salpingo‐oophorectomy, RRSO) on sexual function and the modifying effects of HRT. Design Prospective observational study of women undergoing RRSO and age‐matched comparison group who retained their ovaries. Setting High‐risk clinics and general population.
Martha Hickey, Trevor Tejada‐Berges, Susan M. Domchek, Efrosinia O. Krejany, Alison Brand, Peixuan Li, Sabine Braat, Sheryl Kingsberg   +7 more
wiley   +1 more source